Winel Fonbah: Elevating Anticoagulation Literacy
Winel Fonbah, Registered Nurse at Regional hospital limbe, shared a post on LinkedIn:
“Elevating Anticoagulation Literacy: A Must-Know Guide for Clinicians!
Navigating the landscape of anticoagulants is fundamental for patient safety and effective treatment of conditions like AFib, DVT, and PE. I came across this excellent breakdown (shared below) and wanted to add some crucial context and clinical insights for my fellow healthcare professionals.
Anticoagulants: The Unsung Heroes of Cardiovascular Care.
In healthcare, few medication classes have as much impact on patient safety as anticoagulants, meds that prevent existing blood clots from getting bigger and stop new ones from forming.
While we often focus on the big names—Heparin, Warfarin (Coumadin), and newer Direct Oral Anticoagulants (DOACs)—what’s equally important is understanding how they differ, how they’re monitored, and how we keep patients safe.
Key Insights:
- Heparin: Fast-acting, short-term therapy; requires aPTT monitoring and has an antidote (Protamine sulfate). Watch for heparin-induced thrombocytopenia.
- Warfarin: Long-term therapy that needs consistent Vitamin K intake and regular INR monitoring, It has a slower onset, with antidotes including Vitamin K and FFP.
- DOACs: A newer class offering long-term protection with fewer monitoring requirements and fewer food interactions. Recently, more antidotes have been approved—making them even safer.
Across all anticoagulants, bleeding precautions remain essential, from avoiding aspirin to using soft toothbrushes and minimizing invasive procedures.
As clinicians, educators, or healthcare leaders, staying updated on these meds isn’t just knowledge—it’s patient safety.
Question for you:
- What’s one insight or tip you think every new nurse or healthcare student should know about anticoagulants?
Drop it in the comments—let’s build a resource together.”

Stay informed with Hemostasis Today.
-
Apr 20, 2026, 12:14Yanki Yarman: Linking Genetic Variants to Clinical Outcomes in Thrombosis
-
Apr 20, 2026, 12:09Syed Sibtain Raza: White Blood Cells – Understanding Morphology for Better Diagnosis
-
Apr 20, 2026, 11:23Bastu Odoka: Jehovah’s Witness News on Transfusion… and a Question Worth Asking
-
Apr 20, 2026, 11:15William Aird: A Physiological Approach to Anemia
-
Apr 20, 2026, 10:59Eric Topol: Is the Interferon Pathway a Key Driver of Inflammaging and Aging
-
Apr 20, 2026, 10:47Emmanuel J Favaloro: Emerging Perspectives on Extracellular Vesicles in Hemophilia
-
Apr 20, 2026, 10:21Pierpaolo Di Micco: Honored to Join the ESVM Congress in Lausanne
-
Apr 20, 2026, 08:17Heghine Khachatryan: Key Takeaways from Day 1 – WFH 2026 World Congress
-
Apr 20, 2026, 08:10Justin Nelson-Deering։ Celebrating World Hemophilia Day in Pediatric Care